Sort
30,917 grants matching “tumor microenvironment”
A pro-metastatic secretory pathway activated by p53 loss in lung cancer
$542,703Jonathan M Kurie · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Leveraging Biologically Specific PET/MRI Monitoring and Therapeutic Modulation of the Hypoxic Glioblastoma Tumor Immune Microenvironment into Improved Outcomes
$542,641Ramon Francisco Barajas · Oregon Health & Science University · R37 · FY2025 · CA
Single Cell Genome-Wide Myeloid Response Profiling in Immunotherapy
$542,592Allon Moshe Klein · Harvard Medical School · R01 · FY2020 · CA
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells
$542,504Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2024 · CA
Targeting Novel Pathways in JMML
$542,416Reuben Kapur · Indiana University Indianapolis · R01 · FY2022 · HL
Targeting Novel Pathways in JMML
$542,416Reuben Kapur · Indiana University Indianapolis · R01 · FY2021 · HL
Chemokine interaction with CXCR4 and ACKR3: structure and activation mechanisms
$542,393Tracy M Handel · University Of California, San Diego · R01 · FY2017 · GM
Chemokine interaction with CXCR4 and ACKR3: structure and activation mechanisms
$542,393Tracy M Handel · University Of California, San Diego · R01 · FY2019 · GM
Small molecule probes of MYC stability and function intumorigenesis
$542,383Sarki A. Abdulkadir · Northwestern University At Chicago · R01 · FY2024 · CA
Mechanism of Activity of Lonidamine
$542,325Jerry D Glickson · University Of Pennsylvania · R01 · FY2017 · CA
Mechanism of Activity of Lonidamine
$542,325Jerry D Glickson · University Of Pennsylvania · R01 · FY2016 · CA
CTCF in CD8 T cell homeostasis and anti-viral/tumor immunity
$542,314Hai-Hui Xue · Hackensack University Medical Center · R01 · FY2022 · AI
Antigen-Presenting Cell Control of CD8+ T Cell Exhaustion in Cancer
$542,252Ming Li · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Antigen-Presenting Cell Control of CD8+ T Cell Exhaustion in Cancer
$542,252Ming Li · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Artificial, Humanized Stem Cell Niches
$542,171Biju Parekkadan · Rutgers, The State Univ Of N.J. · R01 · FY2021 · EB
Development of multifunctional drug and immune modulator delivery nanoparticles for the treatment of cancer patients with comorbid atherosclerosis
$542,085Lily Yang · Emory University · R01 · FY2021 · CA
Manipulating normal estrogen physiology as a therapeutic approach in cancer
$542,002Donald P McDonnell · Duke University · R01 · FY2025 · CA
Development of a novel therapy targeting the tumor microenvironment in inflammatory breast cancer
$541,958Naoto T Ueno · University Of Hawaii At Manoa · R01 · FY2024 · CA
DCE MRI Study for Breast Cancer.
$541,897Sungheon Gene Kim · New York University School Of Medicine · R01 · FY2014 · CA
Elucidating genetics of response to immune checkpoint blockade in lung cancer
$541,884Naiyer A Rizvi · Columbia University Health Sciences · R01 · FY2019 · CA
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors
$541,844Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2019 · CA
Role of S.aureus in Cutaneous T Cell Lymphoma Pathogenesis
$541,819Sergei Borisovich Koralov · New York University School Of Medicine · R01 · FY2023 · CA
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors
$541,817Yao Liang Tang · Augusta University · R01 · FY2017 · AR
Tumor-barcoding coupled with high-throughput sequencing for quantitative radiogenomics of the abscopal response in NSCLC
$541,670Phuoc T. Tran · University Of Maryland Baltimore · R01 · FY2023 · CA
Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion
$541,659Michael M. Ittmann · Baylor College Of Medicine · U01 · FY2013 · CA